No abstract available
Keywords:
United States Food and Drug Administration; cancer; cardiovascular disease; clinical trials as topic; underrepresentation.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Cardiovascular Diseases / diagnosis
-
Cardiovascular Diseases / epidemiology*
-
Clinical Trials as Topic*
-
Comorbidity
-
Databases, Factual
-
Eligibility Determination
-
Health Status
-
Humans
-
Neoplasms / diagnosis
-
Neoplasms / drug therapy*
-
Neoplasms / epidemiology
-
Patient Selection*
-
Prevalence
-
Risk Factors
-
Treatment Outcome
-
United States / epidemiology
-
United States Food and Drug Administration